Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
cell decrease » cells decrease (Expand search), cells decreases (Expand search), will decrease (Expand search)
decrease any » decrease and (Expand search), decreases and (Expand search), decreased and (Expand search)
any decrease » and decrease (Expand search), can decrease (Expand search), may decrease (Expand search)
primary cell » primary care (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
cell decrease » cells decrease (Expand search), cells decreases (Expand search), will decrease (Expand search)
decrease any » decrease and (Expand search), decreases and (Expand search), decreased and (Expand search)
any decrease » and decrease (Expand search), can decrease (Expand search), may decrease (Expand search)
primary cell » primary care (Expand search)
1
“...Background: Primary canine hypothyroidism, an endocrine disorder that causes imbalances in the...”
Access document
Access document
Article
2
“...1-4, PVyear5-9, PVyear10-11, PVyear12-13) 17DD-YF primary vaccination. YF-neutralizing antibodies decrease...”
Access document
Access document
Article
3
4
5
6
7
“...Background: Primary erythrocytosis is a rare myeloproliferative disorder in dogs and cats...”
Access document
Access document
Article
8
“...Background: Primary erythrocytosis is a rare myeloproliferative disorder in dogs and cats...”
Access document
Access document
Article
9
10
11
“... of vimentin and PCNA, indicating a possible decrease in the process of cell proliferation after treatment with...”
Access document
Access document
Article
13
“... target to be used in the design of adequate pasteurisation processes. The objectives of this work were...”
Access document
Access document
Article
14
“..., 600, and 800 kPa at 13 ± 1°C) for 4 or 8 d, promotes any improvement compared to conventional...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
15
16
“...) at 1 day of extraction. After 7 days of extraction, cell viability for GuttaFlow was significantly...”
Access document
Access document
Article
17
18
19
20